Pictet Asset Management’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.4M Hold
967,502
0.02% 514
2025
Q1
$19M Sell
967,502
-4,791
-0.5% -$94.3K 0.02% 510
2024
Q4
$21.9M Buy
972,293
+135,969
+16% +$3.06M 0.02% 478
2024
Q3
$21.4M Buy
836,324
+58,215
+7% +$1.49M 0.02% 481
2024
Q2
$18.2M Buy
+778,109
New +$18.2M 0.02% 489